Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WBI-1001 Cream in Mild to Moderate Plaque Psoriasis
NCT01098721Phase 2Completed
- Sponsor
- Welichem Biotech
- Start
- Jan 2010
- Primary completion
- Sep 2010
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of tapinarof in plaque psoriasis, sponsored by Welichem Biotech. Started Jan 2010; status: completed.
02
Drugs
tapinarof
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01098721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01098721.